Do you recommend switching to a non-dihydropyridine calcium channel blocker with the goal of decreasing proteinuria in a proteinuric, hypertensive CKD patient already on a dihydropyridine calcium channel blocker?

Blood pressure control has a more powerful effect on reducing proteinuria than the type of calcium channel blocker. It is often difficult to achieve the goal of BP < 130/80 mm Hg while on a non-dihydropyridine CCB. I chose to focus on other anti-proteinuric agents like SGLT2-INH, MRA, and ACEi/ARB, ...